Smartwatches and Fitness Bands Reveal Individual Physiological Responses to COVID-19 Vaccine

A new digital health study by researchers at Scripps Research shows how data from wearable sensors, such as smartwatches and fitness bands, can track a person’s physiological response to the COVID-19 vaccination.

The study, published in npj Digital Medicine, analyzed sensor data on sleep, activity and heart rate from over 5,600 individuals. Among the findings, the team showed that the average resting heart rate of participants significantly increased the day following vaccination. The effect appeared to be stronger after the second dose of the Moderna vaccine, compared to the Pfizer-BioNTech vaccine, and more pronounced in younger individuals.

According to lead author Giorgio Quer, PhD, director of Artificial Intelligence at the Scripps Research Translational Institute, this study is a first step toward quantifying the physiological response to vaccination in individuals using commercial sensors.

"Investigating the physiological signals in the period around vaccination can help us better understand the variability of vaccine response between people, as well as the changes from an individual norm due to vaccination," Quer says. "As these individual changes are due to a person’s initial immune response to the vaccine, they can potentially help guide future vaccine development to optimize their efficacy and safety, and allow for more precise, individualized vaccine regimens."

The researchers drew their data from a larger project, called Digital Engagement and Tracking for Early Control and Treatment (DETECT) launched in March 2020, in response to the emergence and rapid spread of SARS-CoV-2, the virus that causes COVID-19. DETECT is a mobile-app research platform that allows participants to share physiological and behavioral data gathered through a fitness band or smartwatch, as well as manually entered symptoms, test results and vaccination status.

To determine whether consumer wearables could unearth digital biomarkers of vaccine-induced immune response, the scientists analyzed DETECT sensor data from two weeks before and after each vaccination dose. They compared post-vaccination changes to the participants’ resting heart rate, sleep and activity levels, to their baselines.

The analysis showed that the average resting heart rate of study participants increased significantly the day following vaccination, peaking two days post-vaccination, and returning to normal four days after the first dose and six days after the second. In addition to increases in resting heart rate being higher after the second dose of the Moderna versus the Pfizer-BioNTech vaccine, the study suggests that prior COVID-19 infection was linked with a significantly higher resting heart rate increase after the first vaccine dose relative to those without prior infection. This increase is consistent with an expected greater immune response for these individuals.

Findings also show that women experienced greater changes than men in resting heart rate in the five days following vaccination after the first dose, and that individuals under the age of 40 had higher changes in resting heart rate than older individuals, but only after the second dose.

Activity and sleep patterns appeared to be minimally affected by the first dose, but a significant decrease in activity and an increase in sleep relative to baseline were observed immediately after the second vaccine dose.

"While the link between physiological response and immune response still requires further investigation, digital tracking could provide a novel way to identify individuals who may not be responding optimally to the vaccine," says Steven Steinhubl, MD, associate professor at Scripps Research and senior author of the study.

"DETECT really shows the power of wearable sensor data in furthering our understanding of multiple facets of COVID-19," Quer says. "We hope to continue to expand this research by growing our study cohort further, which will allow us to delve into important questions regarding breakthrough infections and other areas that are currently poorly understood."

Quer, G., Gadaleta, M., Radin, J.M. et al.
Inter-individual variation in objective measure of reactogenicity following COVID-19 vaccination via smartwatches and fitness bands.
npj Digit. Med. 5, 49, 2022. doi: https://doi.org/10.1038/s41746-022-00591-z

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...